<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Oncohematology</journal-id><journal-title-group><journal-title xml:lang="en">Oncohematology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкогематология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8346</issn><issn publication-format="electronic">2413-4023</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">385</article-id><article-id pub-id-type="doi">10.17650/1818-8346-2019-14-4-67-72</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>INFECTION PROBLEMS IN ONCOHEMATOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ПРОБЛЕМЫ ИНФЕКЦИЙ В ОНКОГЕМАТОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Generalized granulomatous inflammation caused by <italic>Candida lusitaniae</italic> in a patient with myelofibrosis</article-title><trans-title-group xml:lang="ru"><trans-title>Генерализованное гранулематозное воспаление, вызванное <italic>Candida lusitaniae</italic>, у пациента с миелофиброзом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8080-904X</contrib-id><name-alternatives><name xml:lang="en"><surname>Korneva</surname><given-names>Yu. S.</given-names></name><name xml:lang="ru"><surname>Корнева</surname><given-names>Ю. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>28 Krupskoy St., Smolensk 214019; 27 Prospekt Gagarina, Smolensk 214018</p></bio><bio xml:lang="ru"><p>Юлия Сергеевна Корнева</p><p>214019 Смоленск, ул. Крупской, 28; 214018 Смоленск, проспект Гагарина, 27</p></bio><email>ksu1546@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Azovskova</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Азовскова</surname><given-names>О. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>28 Krupskoy St., Smolensk 214019</p></bio><bio xml:lang="ru"><p>214019 Смоленск, ул. Крупской, 28</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shisterova</surname><given-names>O. A.</given-names></name><name xml:lang="ru"><surname>Шистерова</surname><given-names>О. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>19 Zhukova St., Smolensk 214000</p></bio><bio xml:lang="ru"><p>214000 Смоленск, ул. Жукова, 19</p></bio><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Smolensk State Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Smolensk Regional Institute of Pathology</institution></aff><aff><institution xml:lang="ru">ОГБУЗ Смоленский областной институт патологии</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Smolensk Regional Oncology Clinical Dispensary</institution></aff><aff><institution xml:lang="ru">ОГБУЗ Смоленский областной онкологический клинический диспансер</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-12-22" publication-format="electronic"><day>22</day><month>12</month><year>2019</year></pub-date><volume>14</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>67</fpage><lpage>72</lpage><history><date date-type="received" iso-8601-date="2019-12-22"><day>22</day><month>12</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-12-22"><day>22</day><month>12</month><year>2019</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncohematology.abvpress.ru/ongm/article/view/385">https://oncohematology.abvpress.ru/ongm/article/view/385</self-uri><abstract xml:lang="en"><p>This article describes a clinical case demonstrating the difficulties of lifetime and post-mortem diagnosis in a patient with primary myelofibrosis complicated by a generalized fungal infection caused by a rare pathogen such as Candida lusitaniae. Management of such patients in non-specialized department with absence of bone marrow trepanobiopsy results associated with the variety of clinical situations in which such manifestations as neutrophilic leukocytosis with left shift without significant changes in the number of erythrocytes and platelets simultaneously with lymphadenopathy and visualizations of secondary foci in internal organs leads to wrong treatment management. And superposition of several pathological processes (granulomatous inflammation, foci of extramedulary hemopoesis and extensive necrotic changes) causes difficulties even for post-mortem verification of the diagnosis, that demonstrate the interest of this clinical case.</p></abstract><trans-abstract xml:lang="ru"><p>В настоящей статье описывается клинический случай, демонстрирующий сложности прижизненной и посмертной диагностики у пациента с первичным миелофиброзом, осложненным генерализованной грибковой инфекцией, вызванной редким возбудителем Candida lusitaniae. Ведение таких пациентов в непрофильном стационаре при отсутствии результатов трепанобиопсии костного мозга и многообразие клинических ситуаций, при которых могут определяться такие проявления, как нейтрофильный лейкоцитоз со сдвигом влево без значительного уменьшения количества эритроцитов и тромбоцитов совместно с генерализованной лимфаденопатией и визуализацией вторичных очагов во внутренних органах, вызывает особое затруднение, становясь причиной неверной тактики лечения. Наслоение нескольких патологических процессов друг на друга (гранулематозное воспаление, очаги экстрамедуллярного кроветворения и обширные некротические изменения) затрудняет даже посмертную верификацию диагноза.</p></trans-abstract><kwd-group xml:lang="en"><kwd>myelofibrosis</kwd><kwd>generalized candidiasis</kwd><kwd>Candida lusitaniae</kwd><kwd>lymphadenopathy</kwd><kwd>granulomatous inflammation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>миелофиброз</kwd><kwd>генерализованный кандидоз</kwd><kwd>Candida lusitaniae</kwd><kwd>лимфаденопатия</kwd><kwd>гранулематозное воспаление</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Li D., Xia R., Zhang Q. et al. Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study. BMC Infect Dis 2017;17(1):536. DOI: 10.1186/s12879-017-2636-x.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Minari A., Hachem R., Raad I. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis 2001;32(2):186—90. DOI: 10.1086/318473.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Stojanovic P., Stojanovic N., Stojanovic-Radic Z. et al. Surveillance and characterization of Candida bloodstream infections in a Serbian tertiary care hospital. J Infect Dev Ctries 2016;10(6):643-56. DOI: 10.3855/jidc.7970.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Shenep J.L., Kalwinsky D.K., Feldman S., Pearson T.A. Mycotic cervical lymphadenitis following oral mucositis in children with leukemia. J Pediatr 1985;106(2):243—6. DOI: 10.1016/s0022-3476(85)80295-x.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Holzschu D.L., Presley H.L., Miranda M., Phaff H.J. Identification of Candida lusitaniae as an opportunistic yeast in humans. J Clin Microbiol 1979;10(2):202-5.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Atkinson B.J., Lewis R.E., Kontoyian-nis D.P. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med My-col 2008;46(6):541—6. DOI: 10.1080/13693780801968571.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Khan Z., Ahmad S., Al-Sweih N. et al. Candida lusitaniae in Kuwait: Prevalence, antifungal susceptibility and role in neonatal fungemia. PLoS One 2019;14(3):e0213532. DOI: 10.1371/journal.pone.0213532.eCollection2019.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Wawrysiuk S., Rechberger T., Futy-ma K., Miotla P. Candida lusitaniae — a case report of an intraperitoneal infection. Prz Menopauzalny 2018;17(2):94— 6. DOI: 10.5114/pm.2018.77310.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Sanchez V., Vazquez J.A., Barth-Jones D. et al. Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol 1992;30(11):3005—08.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Sarma P.S., Durairaj P., Padhye A. A. Candida lusitaniae causing fatal meningitis. Postgrad Med J 1993;69(817):878—80.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Muadcheingka T., Tantivitayakul P. Distribution of Candida Albicans and nonalbicans Candida species in oral candidiasis patients: Correlation between cell surface hydrophobicity and biofilm forming activities. Arch Oral Biol 2015;60(6):894—901. DOI: 10.1016/j.ar-choralbio.2015.03.002.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Pastor-Pascual F., Espana-Gregori E., Avino-Martinez J., Gallego-Pinazo R. Dacryocystitis caused by Candida lusita-niae. Arch Soc Esp Oftalmol 2007;82(6):365-7.</mixed-citation></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Hmel’nickiy O.K., Hmelynickaya N.M. Pathomorphology of human mycosis. Saint Petersburg: Izdatelskiy dom SPb-MAPO, 2005.432 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Хмельницкий О.К., Хмельницкая Н.М. Патоморфология микозов человека. СПб.: СПбМАПО, 2005. 432 с.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><mixed-citation>Alsan M.M., Issa N.C., Hammond S.P. et al. Candida Albicans cervical lymphadenitis in patients who have acute myeloid leukemia. Clin Lymphoma Myeloma Leuk 2011;11(4):375—7. DOI: 10.1016/j.clml.2011.06.002.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Aucouturier B.M., Albassier M., Rue-da N.A., Le Pape P. Specific human and Candida cellular interactions lead to controlled or persistent infection outcomes during granuloma-like formation. Infect Immun 2016;85(1):e00807-16. DOI: 10.1128/IAI.00807-16.</mixed-citation></ref></ref-list></back></article>
